• Br J Anaesth · Sep 1998

    Randomized Controlled Trial Clinical Trial

    Granisetron-droperidol combination for the prevention of postoperative nausea and vomiting in female patients undergoing breast surgery.

    • Y Fujii, H Toyooka, and H Tanaka.
    • Department of Anaesthesiology, University of Tsukuba, Ibaraki, Japan.
    • Br J Anaesth. 1998 Sep 1;81(3):387-9.

    AbstractWe have compared the efficacy and safety of the combination granisetron-droperidol with each antiemetic alone in preventing postoperative nausea and vomiting (PONV) after breast surgery. In a randomized, double-blind study, 150 female patients received granisetron 3 mg, droperidol 1.25 mg or granisetron 3 mg with droperidol 1.25 mg (n = 50 each) i.v., immediately before induction of anaesthesia. A standard general anaesthetic technique was used. The incidence of PONV during the first 24 h after anaesthesia was 18% with granisetron, 38% with droperidol and 4% with the granisetron-droperidol combination (P < 0.05; overall Fisher's exact probability test). We conclude that the granisetron-droperidol combination was more effective than each antiemetic alone in the prevention of PONV in female patients undergoing breast surgery.

      Pubmed     Free full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…